Articles & Posts

  • May 4, 2021
  • Comments (0 )
  • Continued here: AXIM Biotechnologies Introduces Diagnostics to Measure Immunity Against Emerging SARS-CoV-2 Variants

  • May 4, 2021
  • Comments (0 )
  • Go here to see the original: CohBar to Announce 2021 First Quarter Financial Results and Provide Business Update on May 17, 2021

  • May 4, 2021
  • Comments (0 )
  • Read the original: Revive Therapeutics Enters Into Research Agreement with UCSF For Bucillamine As Potential Treatment For Severe COVID-19